This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Alzheimer's Institute of America, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Damon I Papac: Innovator in Cancer Treatment
Introduction
Damon I Papac is a notable inventor based in Mountain Brook, AL (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on therapeutic and diagnostic methods that target specific diseases, particularly cancers.
Latest Patents
Damon I Papac holds a patent for therapeutic and diagnostic methods. This invention relates to methods of treating diseases, especially cancers, that respond favorably to the inhibition of Nicotinamide phosphoribosyltransferase (Nampt). The patent also encompasses therapeutic methods that utilize Nampt inhibitors in combination with NAD biosynthesis precursors. This approach aims to intentionally kill cancer cells while limiting or minimizing toxicity to normal host cells. Additionally, it includes methods for identifying cancers that will be most responsive to treatment with Nampt inhibitors, particularly when administered alongside nicotinic acid. He has 1 patent to his name.
Career Highlights
Damon I Papac is associated with the Alzheimer's Institute of America, Inc., where he applies his expertise in developing innovative treatments. His work has the potential to significantly impact the way cancers are treated, providing new avenues for therapeutic interventions.
Collaborations
Damon collaborates with talented individuals in his field, including Tracey Cristine Fleischer and Daniel M Cimbora. These partnerships enhance the research and development of effective cancer treatments.
Conclusion
Damon I Papac is a pioneering inventor whose work in therapeutic and diagnostic methods is paving the way for advancements in cancer treatment. His innovative approaches hold promise for improving patient outcomes and transforming the landscape of cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile